ABEO - CIK 0000318306
ABEONA THERAPEUTICS INC. (ABEO) reported revenue of $5.82M for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Revenue | Change |
|---|---|---|
| FY 2025 | $5.82M | +66.3% |
| FY 2023 | $3.50M | +147.5% |
| FY 2022 | $1.41M | -52.9% |
| FY 2021 | $3.00M | -70.0% |
| FY 2020 | $10.00M | +233.6% |
| FY 2018 | $3.00M | +258.2% |
| FY 2017 | $837.00K | -5.8% |
| FY 2016 | $889.00K | -14.5% |
| FY 2015 |
ABEONA THERAPEUTICS INC. (ABEO) reported revenue of $5.82M for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2010 and fiscal 2025, ABEONA THERAPEUTICS INC.'s revenue grew from $481.00K to $5.82M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $1.04M |
| +12.4% |
| FY 2014 | $925.00K | -54.7% |
| FY 2013 | $2.04M | -53.6% |
| FY 2012 | $4.40M | +139.5% |
| FY 2011 | $1.84M | +282.3% |
| FY 2010 | $481.00K | - |